Oriflame Cosmetics agrees ¤130m
Credit Facility to support growth
Oriflame Cosmetics S.A. today agreed a ¤130m three-year Term Loan and
Revolving Credit Facility with its core banks, with which Oriflame
will increase its co-operation.
The Facility will be used to support further growth and provides
financing in addition to the existing ¤375m credit facility, which is
to be renegotiated by April 2011.
"We are happy to have agreed this additional credit facility with the
support of our core banks. Now we have all necessary financing in
place for strategic purposes and to support our continued growth",
comments Gabriel Bennet, CFO at Oriflame Cosmetics S.A.
The Facility is co-ordinated by SEB. Nordea and SEB are Mandated Lead
Arrangers. The Facility was oversubscribed and the agreed amount has
been increased above what was initially requested. The following
banks joined the Facility (listed in alphabetic order):
DnB NOR Bank, Co-Arranger
ING Bank NV,
Co-Arranger
Nordea Bank AB (publ), Mandated Lead
Arranger
Skandinaviska Enskilda Banken AB (publ), Mandated Lead
Arranger
For additional information, please contact:
Gabriel Bennet,
CFO +41 798
263 713
Patrik Linzenbold, IR
+46 765 42 27 09
Micael Ljunggren, Head of Loan Origination SEB +46 707 72 32
17
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.